NuVasive (NUVA) PT Raised to $84 at Jefferies Following Results

Jefferies analyst Raj Denhoy reiterates Buy rating and raises price target on NuVasive Inc. (NASDAQ: NUVA) to $84 (from $79), as the company delivered unexpected upside with fourth quarter revenues above consensus, yet provided guidance that appears conservative.

Denhoy comments, "NUVA progresses down a path of substantially above market spine growth and improving operating performance. Still, the pace of margin expansion is appearing more measured as the company continues to invest in its many growth opportunities. Upside potential in both sales and EPS keeps us engaged; PT to $84."

You May Also Be Interested In

• Zscaler (ZS) PT Raised to $220 at Jefferies
• Targa Resources (TRGP) PT Raised to $324 at Wells Fargo
• Alumis Inc (ALMS) PT Lowered to $25 at Wells Fargo